바로가기메뉴

본문 바로가기 주메뉴 바로가기

A Case of Different Response of Miliary Lung and Intracranial Nodules to Antituberculous Therapy

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2008, v.64 no.2, pp.153-157








  • Downloaded
  • Viewed

Abstract

Although a paradoxical response of tuberculosis to antituberculous therapy is not a rare phenomenon, it can be a clinical challenge to differentiate a paradoxical response from treatment failure. A 25-year-old woman was admitted for miliary lung nodules and multiple intracranial nodules. Antituberculous treatment was started with a preliminary diagnosis of tuberculosis based on the history and clinical findings. After one month, the miliary lung nodules improved while the intracranial nodules increased in size and number. Based on a stereotactic biopsy, it was confirmed that the intracranial lesions were tuberculomas. Although the therapeutic regimen was not changed, the symptoms eventually were ameliorated and the intracranial nodules improved two months later.

keywords
Tuberculosis, Paradoxical response, Intracranial tuberculoma

Reference

1.

1.Cheng VC, Ho PL, Lee RA, Chan KS, Chan KK, Woo PC, et al. Clinical spectrum of paradoxical deterioration during antituberculosis therapy in non-HIV-infected patients. Eur J Clin Microbiol Infect Dis 2002;21:803-9.

2.

2.Minn Y. 10 cases of paradoxical expansion of intracranial tuberculomas during chemotherapy. Tuberc Respir Dis 2001;51:260-4.

3.

3.Kang HD, Jun CS, Lee KY, Han JH, Lee HS, Choi J, et al. Miliary tuberculosis and multiple intracranial tuberculoma. Korean J Pediatr Infect Dis 2001;44:443- 50.

4.

4.Jain SK, Kwon P, Moss WJ. Management and outcomes of intracranial tuberculomas developing during antituberculous therapy. Clin Pediatr (Phila) 2005;44: 443-50.

5.

5.Afghani B, Lieberman JM. Paradoxical enlargement or development of intracranial tuberculomas during therapy: case report and review. Clin Infect Dis 1994;19: 1092-9.

6.

6.Ford AL, Foulcher E, Lemckert FA, Sedgwick JD. Microglia induce CD4 T lymphocyte final effector function and death. J Exp Med 1996;184:1737-45.

7.

7.Matyszak MK, Perry VH. Bacillus Calmette-Guerin sequestered in the brain parenchyma escapes immune recognition. J Neuroimmunol 1998;82:73-80.

8.

8.Garcia de Viedma D, Marin M, Ruiz Serrano MJ, Alcala L, Bouza E. Polyclonal and compartmentalized infection by Mycobacterium tuberculosis in patients with both respiratory and extrarespiratory involvement. J Infect Dis 2003;187:695-9.

9.

9. Thrush DC, Barwick DD. Three patients with intracranial tuberculomas with unusual features. J Neurol Neurosurg Psychiatry 1974;37:566-9.

10.

10. Bouchama A, al-Kawi MZ, Kanaan I, Coates R, Jallu A, Rahm B, et al. Brain biopsy in tuberculoma: the risks and benefits. Neurosurgery 1991;28:405-9.

11.

11. Chambers ST, Hendrickse WA, Record C, Rudge P, Smith H. Paradoxical expansion of intracranial tuberculomas during chemotherapy. Lancet 1984;2:181-4.

12.

12. Teoh R, Humphries MJ, O'Mahony G. Symptomatic intracranial tuberculoma developing during treatment of tuberculosis: a report of 10 patients and review of the literature. Q J Med 1987;63:449-60.

13.

13. Arseni C. Two hundred and one cases of intracranial tuberculoma treated surgically. J Neurol Neurosurg Psychiatry 1958;21:308-11.

14.

14. American Thoracic Society, Centers for Disease Control and Prevention and the Infectious Diseases Society. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med 2003;167:603-62.

15.

15. Lees AJ, MacLeod AF, Marshall J. Cerebral tuberculoma developing during treatment of tuberculous meningitis. Lancet 1980;1:1208-11.

16.

16. Hejazi N, Hassler W. Multiple intracranial tuberculomas with atypical response to tuberculostatic chemotherapy. Infection 1997;25:233-9.

Tuberculosis & Respiratory Diseases